跳至主要内容
临床试验/NCT01215370
NCT01215370已完成不适用

Effect of Arginine-rich Dietary Protein on Postprandial Metabolism, Inflammation and Endothelial Function

Wageningen University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Postprandial metabolic, inflammatory and endothelial response

研究概览

简要总结

The main objective is to investigate the postprandial effect of arginine-rich protein (i.e. pea-protein) on metabolic control, inflammation and endothelial function after a high-fat meal in subjects with characteristics of the metabolic syndrome.

详细描述

Arginine is potential interesting considering the metabolic syndrome. Studies so far indicated both long-term effects, as well as acute - postprandial - actions; especially when metabolism is already challenged, e.g. in diabetic patients or after a high-fat meal. If arginine-rich proteins are equally effective is not known. Therefore we are interested in the effect of (arginine rich) protein on postprandial (dys)metabolism, inflammation and endothelial function, within 6 hours after a meal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • male gender
  • central obesity: waist circumference ≥94 cm
  • plus any one of the following four factors:
  • raised triglyceride level: ≥1.7 mmol/L;
  • reduced high-density lipoprotein (HDL) cholesterol: <1.03 mmol/L
  • raised blood pressure: systolic blood pressure ≥130 mmHg or diastolic BP ≥85 mmHg or use of blood pressure lowering medication
  • raised fasting plasma glucose ≥ 5.6 mmol/L
  • Additional inclusion criteria:
  • age 45-70 years
  • body weight should be stable for 3 months
  • stable exercise habits during the last 6 months, and not participating in any vigorous exercise program

排除标准

  • tobacco smoking
  • (undiagnosed) diabetes - but not impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) as evaluated by an oral glucose tolerance test at screening
  • active hearth disease, i.e. history of myocardial infarction or angina pectoris
  • following, or have recently followed a (weight-loss) diet
  • drug uses knowing to interfere with the objectives of the study
  • oral corticosteroids, lipid-lowering drugs (statins)
  • allergic to cow milk / dairy products or gluten
  • vegetarians
  • received inoculations within 2 months of starting or planned to during the study
  • donated or intended to donate blood 2 months before till two months after the study
  • abuse of drugs and/or alcohol
  • participation in another biomedical study within 1 month before the first screening visit
  • not agreeable to be informed about possible distorted blood values which could be found by screening

结局指标

主要结局

Postprandial metabolic, inflammatory and endothelial response

时间窗: up to 6 hours

Metabolic: Plasma glucose, insulin and triglyceride levels (T= 0,1,2,3,4,5 and 6 hrs) Inflammatory: C-reactive protein (CRP), Plasminogen activator inhibitor-1 (PAI-1), Tumor necrosis factor-alpha (TNF-a), Interleukin-6 (IL-6), Inter-Cellular Adhesion Molecule-1 (ICAM-1) and Monocyte chemotactic protein-1 (MCP-1) (T=0, 2, 4 and 6 hrs). Endothelial function: Macro vascular regional arterial stiffness by Pulse Wave Analysis (PWA) (T=0, 3 and 6 hrs).

次要结局

  • Satiety markers and Oxidative stress(up to 6 hours)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验